Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures

Author:

Schäfer Theresa E.ORCID,Knol Lisanne I.,Haas Ferdinand V.,Hartley Anna,Pernickel Sophie C.S.,Jády Attila,Finkbeiner Maximiliane S.C.,Achberger Johannes,Arelaki Stella,Modic Živa,Schröer Katrin,Zhang Wenli,Schmidt Barbara,Schuster Philipp,Haferkamp Sebastian,Doerner JohannesORCID,Gebauer Florian,Ackermann MaximilianORCID,Kvasnicka Hans-Michael,Kulkarni Amit,Bots Selas T.F.,Kemp VeraORCID,Hawinkels Lukas J.A.C.,Poetsch Anna R.,Hoeben Rob C.,Ehrhardt Anja,Marchini Antonio,Ungerechts Guy,Ball Claudia R.,Engeland Christine E.ORCID

Publisher

Elsevier BV

Reference87 articles.

1. Pancreatic cancer;Mizrahi;Lancet,2020

2. Immune conversion of tumor microenvironment by oncolytic viruses: the protoparvovirus H-1PV case study;Marchini;Front Immunol,2019

3. Clinical landscape of oncolytic virus research in 2020;Macedo;J Immunother Cancer,2020

4. Oncolytic virus immunotherapy;Marchini;Cancers (Basel),2021

5. Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis;Lanson;Cancer Res,2003

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3